A small molecule blocked a cellular channel called KCa1.1, which is known to exist at high levels in rheumatoid arthritis, and reduced the negative effects of the disorder, said a consortium of researchers led by those at Baylor College of Medicine, in a proof-of-principle study that could point to a new therapy for the destructive disease.

Click Here to read more